Clinical Trial: Prostate MRI Analysis by Radiologists and Artificial Intelligence - Disease Identification and Guided Management

U.S., June 16 -- ClinicalTrials.gov registry received information related to the study (NCT07647445) titled 'Prostate MRI Analysis by Radiologists and Artificial Intelligence - Disease Identification and Guided Management' on June 09.

Brief Summary: Prostate cancer is the most common male cancer in 112 countries and makes up 7% of global cancer cases, and is the second leading cause of cancer-related deaths in men.

Normally, men with suspected prostate cancer undergo a prostate MRI, and then a Radiologist would review this scan to identify any suspicious areas for cancer within the prostate. Prostate MRI interpretation, however, is an expert skill with a steep learning curve, and internationally, there is a growing shortage of Radiologist...